Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: Block of initiation of proliferation of Gr-1+ cells-Reference-Cited by-同舟云学术

Specific effect of immunomodulatory quinoline-3-carboxamide ABR-215757 in GM-CSF stimulated bone marrow cell cultures: Block of initiation of proliferation of Gr-1+ cells

Published:2011-08 Issue:8 Volume:11 Page:1045-1051
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Helmersson Sofia,Stenström Martin,Leanderson Tomas,Ivars Fredrik

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference23 articles.

1. Paradoxical effects of LS-2616 (Linomide) treatment in the type II collagen arthritis model in mice;Bjork;Agents Actions,1989

2. The new orally active immunoregulator laquinimod (ABR-215062) effectively inhibits development and relapses of experimental autoimmune encephalomyelitis;Brunmark;J Neuroimmunol,2002

3. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus;Gross;Int Immunopharmacol,2001

4. Inhibition of the development of chronic experimental autoimmune encephalomyelitis by laquinimod (ABR-215062) in IFN-beta k.o. and wild type mice;Runstrom;J Neuroimmunol,2006

5. Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides;Bjork;PLoS Biol,2009

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth;BMC Cancer;2016-07-11

2. Paquinimod reduces skin fibrosis in tight skin 1 mice, an experimental model of systemic sclerosis;Journal of Dermatological Science;2016-07

3. The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: Leukocyte- and context-specific effects;International Immunopharmacology;2014-02

4. Amelioration of Experimental Autoimmune Encephalomyelitis by the Quinoline-3-Carboxamide Paquinimod;The American Journal of Pathology;2013-05